Sign In

S Senda

Director at Genomembrane

S Senda is a prominent figure in the biotechnology sector, currently serving as the Director at Genomembrane Co., Ltd., a company based in Kanagawa, Japan, that specializes in drug transporters and related research and development. Senda has a background in the pharmaceutical industry, having previously held significant roles, including CEO of Senda Biosciences, which was involved in innovative biotechnological research and development.

Under Senda's leadership, Genomembrane has focused on providing transporter-related products and assay services, contributing to advancements in drug discovery and development. The company aims to facilitate various screening systems and tools essential for evaluating drug interactions and pharmacokinetics.123

Senda has also been involved in collaborations that enhance the company's offerings, such as partnerships to supply specialized kits for drug interaction studies.1 His expertise and leadership continue to shape the direction of Genomembrane in the competitive biopharmaceutical landscape.

Highlights

Oct 19 · biopharmadive.com
Laronde, Senda Biosciences merge to create new Flagship company
Transient, Tunable Expression of NTCP and BSEP in MDCKII Cells ...
Qualyst to supply B-Clear hepatocytes kits in Japan

Related Questions

What is Senda Biosciences' main focus?
How did Senda Biosciences merge with Laronde?
What role did Senda Biosciences play in the development of Shingrix?
Who are the key executives at Sail Biomedicines?
What is the significance of the B-Clear Technology for drug development?
S Senda
S Senda, photo 1
S Senda, photo 2
Add to my network

Location

Japan